The company has invested Rs 1.5 billion to set up this plant that would increase company revenues by 15% annually, it said in a filing to the Bombay Stock Exchange.

The new unit would manufacture liquid orals, sterile injectables and cephalosporin block for tablets as well as dry powder injectables, the statement said.

---

Add this page to your favorite Social Bookmarking websites